Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nicorandil for arrhythmia reduction in myocardial infarction patients undergoing angioplasty
IRCT20181104041555N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in myocardial infarction (MI) comparing Nicorandil with Placebo (2 arms). Primary endpoint: Arrhythmia. Started Dec 2018; status: completed.
02
Drugs
nicorandil
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20181104041555N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181104041555N1.